Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates
© Neva Press, Inc. 2005 |
|
CNS Drug ReviewsTable
of Contents
Volume 2, No. 2
| 145 |
|
F-0401: A
Novel Calcium Antagonist with PAF Antagonist Action, as a Potentially Cerebroprotective
Drug for Patients with Ischemic Stroke
Hiroyuki Kato, Noriko Kase, Yutaka Hayashi and Kyuya Kogure |
| 160 |
|
HA 1077: A
Novel Intracellular Calcium Antagonist. 1. Pharmacology
K. Sako, Y. Yonematsu, M. Tsuchiya and T. Asano |
| 175 |
|
EMD 57445: A
Selective Sigma Receptor Ligand with the Profile of an Atypical Neuroleptic
G. D. Bartoszyk, H. M. Bender, J. Hellmann, C. Schorr and C. A. Seyfried |
| 195 |
|
Therapeutic
Potentials of Itasetron (DAU 6215), a Novel 5-HT3 Receptor Antagonist, in the
Treatment of Central Nervous System Disorders
M. Beatrice Passani and Renato Corradetti |
| 214 |
|
Cabergoline, a
Promising Agent for the Treatment of Parkinson's Disease
R. Grondin and Paul J. Bédard |
| 226 |
|
NE-100, a Novel
Sigma Receptor Antagonist
Shigeru Okuyama and Atsuro Nakazato |
| 238 |
|
Treatment
Development Strategies for Alzheimer's Disease
Ernst Wülfert |
|
|
|